Chromatographia

, Volume 62, Issue 7–8, pp 355–361 | Cite as

Validation of an HPLC Method for Determination of Cefepime (a Fourth-Generation Cephalosporin). Determination in Human Serum, Cerebrospinal Fluid, and Urine. Pharmacokinetic Profiles

  • F. J. Jiménez Palacios
  • M. Callejón Mochón
  • J. C. Jiménez Sánchez
  • M. Á. Bello López
  • A. Guiráum Pérez
Article

Abstract

A high-performance liquid-chromatographic method with detection at 256 nm has been developed and validated for analysis of cefepime in several biological matrices. Serum samples were deproteinized with acetonitrile and extracted once with dichloromethane. For urine and cerebrospinal fluid samples, only a microfiltration step was necessary. The method was validated in accordance with the recommendations of the International Conference on Harmonization (ICH), the Food and Drug Administration (FDA), and the Center for Drug Evaluation and Research (CDER). The method was used to determine levels of the drug in the serum, cerebrospinal fluid, and urine of twelve patients treated with Maxipime. The results obtained were compared with those from previously published HPLC methods.

Keywords

Column liquid chromatography Cefepime Serum cerebrospinal fluid and urine Pharmacokinetic profiles 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barbhaiya R, Knupp A, Forgue T, Matzke R, Halstenson E, Opsahl JA, Pittman K (1990) Drug Metab Dispos 19:68–73Google Scholar
  2. Bellido F, Pechere J, Hancock R (1991) Antimicrob Agents Chemother 35:68–72PubMedGoogle Scholar
  3. Nikaido W, Liu W, Rosenberg Y (1990) Antimicrob Agents Chemother 34:337–342PubMedGoogle Scholar
  4. Sanders W Jr, Tenney J, Kessler R (1996) Clin Infect Dis 23:454–461PubMedGoogle Scholar
  5. Modai J (1996) J Chemother 8:83–90PubMedGoogle Scholar
  6. Rodenas V, Parra A, Garcia-Villanova J (1995) J Pharm Biomed Anal 13:1095–1099CrossRefPubMedGoogle Scholar
  7. Fasching C, Peterson L, Gerding D (1986) J Liq Chromatogr 9:1803–1814Google Scholar
  8. Elkhaïli H, Linger L, Monteil H, Jehl F (1997) J Chromatogr B 690:181–188Google Scholar
  9. Rabouan-Guyon S, Guet A, Courtois P, Barthes D (1997) Int J Pharm 154:185–190CrossRefGoogle Scholar
  10. Elkhaïli H, Levêque D, Peter J, Salmon Y, Salmon J, Pompei D, Monteil H, Jehl F (1997) Int J Antimicrob Agents 8:135–141CrossRefGoogle Scholar
  11. Valassis I, Parissi-Poulou M, Macheras P (1999) J Chromatogr B 721:249–255Google Scholar
  12. Breilh D, Lavallee C, Fratta A, Ducint D, Cony-Mckhow P (1999) J Chromatogr B 734:121–127Google Scholar
  13. Calahorra B, Campanero M, Sábada B, Azanza J (1999) Biomed Chromatogr 13:272–275CrossRefPubMedGoogle Scholar
  14. Maddox F, Stewart J (1999) J Liq Chromatogr 22:2807–2813CrossRefGoogle Scholar
  15. Chang Y, Chou M, Lin M, Chen C, Tsai T (2001) J Chromatogr A 914:77–82CrossRefPubMedGoogle Scholar
  16. Cherti N, Kinowski J, Lefrant J, Bressolle F (2001) J Chromatogr B 754:377–386Google Scholar
  17. Özkan S, Zulú B, Zuman P (2002) Anal Chim Acta 457(2):265–274Google Scholar
  18. Jiménez F, Callejón M, Jiménez J, Herrera J (2000) Electroanalysis 4:296–300Google Scholar
  19. Jiménez F, Callejón M, Jiménez J, Herrera J (2003) J Pharm Sci 92:1854–1859CrossRefPubMedGoogle Scholar
  20. Kessler R, Bies M, Buck R, Chrisholm D, Pursiano T, Tsai Y, Misiek M, Price K, Leitner F (1985) Antimicrob Agents Chemother 27:207–216PubMedGoogle Scholar
  21. US Pharmacopeia 24, Validation of compendial methods, section 1225. United States Pharmacopeal Convention, Rockville, MD, 1999Google Scholar
  22. ICH Q2B: Text on validation of analytical procedures methodology (International Conference on Harmonization of Technical Requirements for the Registration of Drugs For Human Use, Geneva, Switzerland, March 1979). Published in Federal Register, 62(96), 19 May 1997, 27463–27467Google Scholar
  23. Center for Drug Evaluation and Research, US Food and Drug Administration and Center for Veterinary Medicine (2001) Guidance for industry. Bioanalytical method validation. USFDA, Rockville, MDGoogle Scholar
  24. National Committee for Clinical Laboratory Standards (2001) Performance standards for antimicrobial testing. NCCLS document. M100-S11, vol 21, no. 1. Wayne, PA, NCCLSGoogle Scholar
  25. Craig W (1995) Diag Microb Inf Dis 22:89–96CrossRefGoogle Scholar
  26. Jiménez M, Jiménez F, Pichardo C, Callejón M, Pachón M, Jiménez J, Flores J (2003) Farmacocinética y farmacodinámica de cefepima en suero y en LCR. V Congreso de la Sociedad Andaluza de Enfermedades Infecciosas, SevillaGoogle Scholar
  27. Jiménez M, Jiménez F, Bellido M, Pichardo C, Callejón M, Pachón M, Jiménez J, Flores J (2004) Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of cefepime in serum and cerebrospinal fluid. 14th European Congress of Clinical Microbiology and Infectious Diseases, PragueGoogle Scholar
  28. Lutsar I, Friedland IR (2000) Clin Pharmacokinet 39:335–343PubMedGoogle Scholar

Copyright information

© Friedr. Vieweg & Sohn/GWV Fachverlage GmbH 2005

Authors and Affiliations

  • F. J. Jiménez Palacios
    • 1
  • M. Callejón Mochón
    • 1
  • J. C. Jiménez Sánchez
    • 1
  • M. Á. Bello López
    • 1
  • A. Guiráum Pérez
    • 1
  1. 1.Department of Analytical ChemistryFaculty of ChemistrySevilleSpain

Personalised recommendations